Press release
January 8, 2026
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
GENELUX Corp (GNLX)
WESTLAKE VILLAGE, Calif. , Jan. 08, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an underwritten public offering of 6,666,667 shares of its common stock at a price to the public of $3.00 per